The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

In today’s health-conscious world, prostate health has become an essential focus for men of all ages. As the population ages, issues related to prostate health have surged dramatically, sparking a ...